Should You Continue Tamplus Despite Normal PSA?
Yes, you should continue Tamplus (tamsulosin plus finasteride) even though your PSA is now normal—PSA normalization is an expected pharmacological effect of finasteride, not an indication to stop therapy. The decision to continue or discontinue treatment should be based on your urinary symptoms, prostate size, and risk of disease progression, not PSA levels alone.
Understanding Why PSA Decreases on Finasteride
The finasteride component of Tamplus predictably reduces PSA by approximately 50% within 6 months of treatment 1. This occurs because:
- Finasteride shrinks the prostate glandular epithelium (the source of PSA production) by 15-25% 2
- PSA reduction continues beyond the first year, with median decreases of 40-57% by 48 months 3
- This PSA decrease is therapeutic and expected, not a sign that treatment can be stopped
Critical caveat: A "normal" PSA on finasteride does not mean your prostate has returned to normal or that you no longer need treatment. The medication is actively suppressing PSA production while continuing to provide symptom relief and prevent disease progression.
When to Continue Treatment
Continue Tamplus if you have:
- Moderate-to-severe lower urinary tract symptoms (IPSS ≥8) that have improved on therapy 2
- Prostate volume >30cc or baseline PSA >1.5 ng/mL before starting treatment 2
- Risk factors for progression: larger prostate volume (especially >40cc), higher baseline PSA, or age-related concerns 4
The 2021 AUA guidelines emphasize that 5α-reductase inhibitors like finasteride provide sustained symptom improvement for 6-10 years and reduce clinical progression events including acute urinary retention and need for surgery 2. The CombAT trial demonstrated that combination therapy (dutasteride plus tamsulosin, similar to your regimen) reduces the risk of clinical progression across all baseline subgroups compared to monotherapy 4.
Monitoring PSA While on Treatment
Important monitoring principles:
- Establish a new PSA baseline after 6-12 months of finasteride therapy 1
- Any confirmed rise from your lowest PSA value (nadir) may signal prostate cancer and requires evaluation, even if the absolute value remains "normal" for untreated men 1
- For isolated PSA interpretation after 6+ months on finasteride, double the measured PSA value to compare with normal ranges for untreated men 3, 1
The FDA label explicitly states that finasteride can decrease PSA even in the presence of prostate cancer 1. Therefore, rising PSA trends matter more than absolute values.
When Stopping Might Be Considered
Discontinuation may be appropriate only if:
- Your urinary symptoms have completely resolved and remained absent for an extended period
- You had minimal symptoms to begin with (IPSS <8)
- Your prostate was not significantly enlarged (<30cc) at baseline
- You discuss with your urologist and understand the risk of symptom recurrence and disease progression
Common pitfall: Patients often want to stop medication when symptoms improve, not recognizing that the improvement is because of the medication. Stopping finasteride will lead to prostate re-growth, PSA rise back toward baseline (over months), and likely symptom recurrence 2.
The Bottom Line
Your normal PSA is a sign that finasteride is working as intended, not a reason to stop. The combination therapy provides ongoing benefits in symptom control and prevention of BPH progression that extend well beyond PSA reduction 2, 4. Unless you're experiencing intolerable side effects or your symptoms have completely resolved with a small baseline prostate, continuing Tamplus is the evidence-based approach for long-term management of benign prostatic hyperplasia.